PHA
Showing 51 - 75 of 230
Direct Oral Anticoagulants (DOACs) in Hypercoagulable States
Completed
- Hypercoagulable States
- Observational
-
Dallas, TexasMethodist Dallas Medical Center
Dec 9, 2021
Graft Vs Host Disease, Graft-versus-host-disease Trial in San Francisco (CliniMacs®)
Recruiting
- Graft Vs Host Disease
- Graft-versus-host-disease
- CliniMacs®
-
San Francisco, CaliforniaUniversity of California, San Francisco
Aug 2, 2022
Cytokine Storm Trial in Amman (Vitamin D3)
Completed
- Cytokine Storm
- Vitamin D3
-
Amman, JordanMahmoud S Abu-Samak
Feb 23, 2022
Small Cell Lung Cancer, Lung Cancer Trial in Belgium, Netherlands (Radiation Prophylactic Cranial Irradiation, Radiation
Completed
- Small Cell Lung Cancer
- Lung Cancer
- Radiation Prophylactic Cranial Irradiation
- Radiation Hippocampal Avoidance PCI
-
Antwerpen, Belgium
- +8 more
Jan 20, 2022
Autoimmune Diseases, Epilepsy, Autonomic Dysfunction Trial in Louisville (Vagal nerve stimulation (VNS))
Recruiting
- Autoimmune Diseases
- +3 more
- Vagal nerve stimulation (VNS)
-
Louisville, Kentucky
- +1 more
Nov 7, 2022
Vancomycin Monitoring
Enrolling by invitation
- MRSA
- Retrospective chart review
-
Dallas, TexasMethodist Dallas Medical Center
May 24, 2022
Analysis of Cardiac Biomarker Racial Discrepancies
Enrolling by invitation
- Heart Failure
- No intervention
-
Dallas, TexasMethodist Dallas Medical Center
Dec 20, 2022
Prevalence of Acute Hepatic Porphyria
Not yet recruiting
- Acute Hepatic Porphyria
- Dosage of Delta-aminolevulinic acid and Porphobilinogen
- (no location specified)
Jun 11, 2021
Rare Genetic Disorders of the Breathing Airways
Completed
- Kartagener Syndrome
- +3 more
-
Palo Alto, California
- +8 more
Aug 9, 2022
Quantifying Gram-negative Resistance to Empiric Therapy in
Active, not recruiting
- Gram-Negative Bacterial Infections
- IV antibiotic treatment from prior
- differing IV antibiotic treatment
-
Dallas, TexasMethodist Dallas Medical Center
Mar 1, 2022
Old Age; Atrophy Trial in Valencia (Suspension training, Strength training)
Recruiting
- Old Age; Atrophy
- Suspension training
- Strength training
-
Valencia, SpainUniversity of Valencia
Jan 23, 2023
Gram-negative Resistance for HAP/VAP in the Intensive Care Unit
Enrolling by invitation
- Ventilator-associated Pneumonia
- Hospital-acquired Pneumonia
- Observational
-
Dallas, TexasMethodist Dallas Medical Center
Dec 9, 2021
Neoadjuvant Immunotherapy in Advanced NSCLC
Not yet recruiting
- Lung Cancer, Non-small Cell
- Immunotherapy
-
San Francisco, CaliforniaPower Life Sciences
Jan 21, 2022
Cytokine Storm, Cytokines Trial in Amman (300 mg of omega3-FA)
Completed
- Cytokine Storm
- Cytokines
- 300 mg of omega3-FA
-
Amman, JordanMahmoud S Abu-Samak
Feb 23, 2022
Clostridioides Difficle Infection in Solid Organ Transplant
Completed
- Infection in Solid Organ Transplant Recipients
- Solid organ transplant
-
Dallas, TexasJessica Rago
Feb 3, 2022
Time to Lose Weight? Comparison of Weight-based and
Completed
- Septic Shock
- Weight, Body
-
Dallas, TexasMethodist Dallas Medical Center
Nov 9, 2021
Balance, Activity-specific Balance Confidence and Quality of
Recruiting
- Idiopathic Parkinson's Disease
- Assessment
-
Niğde, TurkeyNigde Omer Halisdemir University Treaning and Research Hospital
Jan 8, 2023
Viral Infections After HSCT Trial in Washington (VSTs)
Active, not recruiting
- Viral Infections After HSCT
- VSTs
-
Washington, District of ColumbiaChildrens National Medical Center
Aug 30, 2022
Long-Term Effects of CBT on Quality of Life in Adults With ADHD
Not yet recruiting
- Attention Deficit Hyperactivity Disorder
- cognitive behavioural therapy
- (no location specified)
Mar 11, 2022
Diabetes, Type 2, Kidney Diseases Trial in Amman (Soft gelatin capsules each contains 50 000 IU VD3 (cholecalciferol)
Completed
- Diabetes Mellitus, Type 2
- Kidney Diseases
- Soft gelatin capsules each contains 50 000 IU VD3 (cholecalciferol) equivalents to 1.25 mg.
-
Amman, JordanMahmoud S Abu-Samak
Feb 23, 2022
Systemic Lupus Erythematosus, Lupus Nephritis Trial (Mycophenolate Mofetil, Tacrolimus, Glucocorticoid)
Not yet recruiting
- Systemic Lupus Erythematosus
- Lupus Nephritis
- Mycophenolate Mofetil
- +2 more
- (no location specified)
Jun 21, 2023
Scleroderma, Systemic Trial in Athens (MABp1 (Bermekimab) OR Placebo, MABp1 (Bermekimab))
Completed
- Scleroderma, Systemic
- MABp1 (Bermekimab) OR Placebo
- MABp1 (Bermekimab)
-
Athens, Attiki, Greece
- +1 more
Sep 28, 2022
Newborn Hypothermia Trial in Dar Es Salaam (Celsi Warmer)
Recruiting
- Newborn Hypothermia
- Celsi Warmer
-
Dar Es Salaam, TanzaniaMuhimbili University of Health and Allied Sciences (MUHAS)
Aug 18, 2023